Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study
Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study have?
Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study has 103 citations in the OpenAlex counts ScholarIQ stores.
When was Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study published?
Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study has 2015 year in the ScholarIQ index.
What is the open-access status of Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study?
Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study has bronze oa status in the ScholarIQ index.
What is the DOI of Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study?
The DOI for Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study is on the source record.
What is the PMID of Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study?
The PMID for Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study is on the source record.
What is the OpenAlex record for Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study?
The OpenAlex for Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study is on the source record.